Patient Recruitment in Nebraska

TheraNovex connects clinical trial sponsors with pre-screened, eligible patients across Nebraska, including Omaha, Lincoln, Bellevue, and beyond.

Who qualifies: Adults with confirmed CAG repeat expansion (≥36), including prodromal and manifest HD patients.

Recruitment challenges: Genetic confirmation requirements and small patient population necessitate national recruitment.

Our approach: HD clinic networks, HDSA chapter partnerships, and genetic pre-screening coordination.

Our recruitment network spans all major metropolitan areas in Nebraska, ensuring broad geographic coverage for your trial.